Improving children's medicines

Archives of Disease in Childhood

Volumn 91, Issue 7, 2006, Pages 550-551

  Choonara, Imti ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; DRUG SAFETY; EUROPE; HEALTH PRACTITIONER; HUMAN; LAW; MEDICAL PRACTICE; PACKAGING; PEDIATRICS; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM;

CHILD; EUROPE; HUMANS; LEGISLATION, DRUG; PHARMACEUTICAL PREPARATIONS;

EID: 33745789168     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.094805     Document Type: Review

References (19)

1. McLay JS, Tanaka M, Ekins-Daukes S, et al. A prospective questionnaire assessment of attitudes and experiences of off label prescribing amongst hospital based paediatricians. Arch Dis Child 2006;91:584-7.
2. Turner S, Nunn AJ, Choonara I. Unlicensed drug use in children in the UK. Paediatr Perinat Drug Ther 1997;1:52-5.
3. Turner S, Longworth A, Nunn AJ, et al. Unlicensed drug use on paediatric wards. BMJ 1998;316:343-5.
4. Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999;80:F142-5.
5. McIntyre J, Conroy S, Avery A, et al. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child 2000;83:498-501.
6. Bonati M, Choonara I, Hoppu K, et al. Closing the gap in drug therapy. Lancet 1999;353:1625.
7. Autret E, Bonati M, Choonara I, et al. Medicines for children. Paediatr Perinat Drug Ther 2000;4:23.
8. Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off-label drug use in paediatric wards in European countries. BMJ 2000;320:79-82.
9. Turner S. Unlicensed and off label drug use in Australia. Paediatr Perinat Drug Ther 2000;4:24-27.
10. Turner S, Nunn AJ, Fielding K, et al. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr 1999;88:965-968.
11. Saint-Raymond A, Seigneuret N. Medicines for children: time for Europe to act. Paediatr Perinat Drug Ther 2005;6:142-6.
12. Roberts R, Rodriguez W, Murphy D, et al. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. JAMA 2003;7:905-11.
13. Jong GW, van den Anker J, Choonara I. FDAMA's written request list: medicines for children. Lancet 2001;357:398.
14. Choonara I, Dewit O, Harrop E, et al. Training in paediatric clinical pharmacology in the UK. Br J Clin Pharmacol 2004;58:217-18.
15. Bonati M, Pandolfini C, Rossi V, et al. Launch of a European paediatric clinical trials register. Paediatr Perinat Drug Ther 2004;6:38-9.
16. Sammons HM, Naylor C, Choonara I, et al. Should paediatricians support the European Paediatric Clinical Trials Register? Arch Dis Child 2005;90:559-60.
17. Whittington CJ, Kendall T, Fonagy P, et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004;363:1341-5.
18. Choonara I. Paediatric pharmacovigilance. Paediatr Perinat Drug Ther, (in press).
19. van den Ouweland FA, Brown E, Carr DJ. Data monitoring committees in paediatric research. Paediatr Perinat Drug Ther 2004;6:81-8.